Analysis of <it>Bordetella pertussis </it>pertactin and pertussis toxin types from Queensland, Australia, 1999–2003
<p>Abstract</p> <p>Background</p> <p>In Australia two acellular <it>Bordetella pertussis </it>vaccines have replaced the use of a whole cell vaccine. Both of the licensed acellular vaccines contain the following three components; pertussis toxoid, pertussis...
Main Authors: | Slack Andrew T, Byrne Shane |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2006-03-01
|
Series: | BMC Infectious Diseases |
Online Access: | http://www.biomedcentral.com/1471-2334/6/53 |
Similar Items
-
Bordetella pertussis Strain Lacking Pertactin and Pertussis Toxin
by: Margaret M. Williams, et al.
Published: (2016-02-01) -
Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia
by: Connie Lam, et al.
Published: (2014-04-01) -
Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
by: Longhuan Ma, et al.
Published: (2021-06-01) -
Construction of <it>Bordetella pertussis </it>strains with enhanced production of genetically-inactivated Pertussis Toxin and Pertactin by unmarked allelic exchange
by: Buasri Wasin, et al.
Published: (2012-04-01) -
Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013–2017
by: Zheng Xu, et al.
Published: (2019-06-01)